Visfatin Enhances CXCL8, CXCL10, and CCL20 Production in Human Keratinocytes
Authors:
Open Access
- 14 June 2011
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 152 (8) , 3155-3164
Abstract
Psoriasis patients are frequently associated with metabolic syndromes. Such associations are possibly mediated by adipokines. We investigated the in vitro effects of visfatin (an adipokine) on chemokine expression in human keratinocytes. Normal human keratinocytes were incubated with visfatin, and their chemokine production was analyzed by ELISA and RT-PCR. Visfatin enhanced TNF-α-induced CXC chemokine ligand (CXCL) 8, CXCL10, and CC chemokine ligand (CCL) 20 secretion and mRNA expression in keratinocytes, although visfatin alone was ineffective. A small interfering RNA against nuclear factor-κB (NF-κB) p65 suppressed the visfatin-induced production of CXCL8, CXCL10, and CCL20 whereas a small interfering RNA against signal transducer and activator of transcription (STAT) 3 suppressed CXCL8 induction. This indicates the involvement of NF-κB in CXCL8, CXCL10, and CCL20 induction by visfatin and the involvement of STAT3 in CXCL8 induction. Visfatin alone increased the transcriptional activity and tyrosine phosphorylation of STAT3, which was suppressed by Janus kinase (JAK) 2 inhibitor. Visfatin enhanced basal and TNF-α-induced NF-κB activity and inhibitory κB (IκB) α phosphorylation, which was suppressed by IκB kinase inhibitor. Visfatin induced the tyrosine and serine phosphorylation of JAK2 and IκB kinase α/β, respectively. Intraperitoneal injection of visfatin elevated mRNA and protein levels of CXCL1, CXCL10, and CCL20 in murine skin. These results suggest that visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes and homologous chemokine production in murine skin. Visfatin may induce the infiltration of type 1 or type 17 helper T cells or neutrophils to the skin via chemokine induction and thus link metabolic syndromes to psoriasis.Keywords
This publication has 37 references indexed in Scilit:
- Obesity and psoriasis: From the Medical Board of the National Psoriasis FoundationJournal of the American Academy of Dermatology, 2010
- Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritisArthritis & Rheumatism, 2010
- Skin immune sentinels in health and diseaseNature Reviews Immunology, 2009
- Serum high molecular weight adiponectin levels are decreased in psoriasis patientsJournal of Dermatological Science, 2009
- Serum leptin levels, skin leptin and leptin receptor expression in psoriasisBritish Journal of Dermatology, 2008
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T CellsJournal of Investigative Dermatology, 2008
- Obesity, Waist Circumference, Weight Change, and the Risk of Psoriasis in WomenArchives of internal medicine (1960), 2007
- Visfatin is released from 3T3-L1 adipocytes via a non-classical pathwayBiochemical and Biophysical Research Communications, 2007
- Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating PropertiesThe Journal of Immunology, 2007
- Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in PsoriasisThe Journal of Immunology, 2000